Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques
Background and objectives Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non‐endothelialized, artificial surface to bloo...
Saved in:
| Published in | Vox sanguinis Vol. 112; no. 5; pp. 443 - 452 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
S. Karger AG
01.07.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0042-9007 1423-0410 1423-0410 |
| DOI | 10.1111/vox.12514 |
Cover
Loading…
| Abstract | Background and objectives
Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non‐endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre‐existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support.
Methods
This is a descriptive, self‐reporting cross‐sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple‐choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated.
Results
Our findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support.
Discussion
The lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care. |
|---|---|
| AbstractList | Background and objectives Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non-endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre-existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support. Methods This is a descriptive, self-reporting cross-sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple-choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated. Results Our findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support. Discussion The lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care. Background and objectives Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non‐endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre‐existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support. Methods This is a descriptive, self‐reporting cross‐sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple‐choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated. Results Our findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support. Discussion The lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care. Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non-endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre-existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support. This is a descriptive, self-reporting cross-sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple-choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated. Our findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support. The lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care. Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non-endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre-existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support.BACKGROUND AND OBJECTIVESExtracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non-endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre-existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support.This is a descriptive, self-reporting cross-sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple-choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated.METHODSThis is a descriptive, self-reporting cross-sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple-choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated.Our findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support.RESULTSOur findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support.The lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care.DISCUSSIONThe lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care. |
| Author | Hayanga, J. W. A. Welsby, I. J. Triulzi, D. J. Waters, J. H. Esper, S. A. Subramaniam, K. John Wallisch, W. Schears, G. J. Levy, J. H. |
| Author_xml | – sequence: 1 givenname: S. A. orcidid: 0000-0003-4839-8030 surname: Esper fullname: Esper, S. A. email: espersa@upmc.edu organization: University of Pittsburgh – sequence: 2 givenname: I. J. surname: Welsby fullname: Welsby, I. J. organization: Duke University – sequence: 3 givenname: K. surname: Subramaniam fullname: Subramaniam, K. organization: University of Pittsburgh – sequence: 4 givenname: W. surname: John Wallisch fullname: John Wallisch, W. organization: University of Pittsburgh – sequence: 5 givenname: J. H. surname: Levy fullname: Levy, J. H. organization: Duke University – sequence: 6 givenname: J. H. surname: Waters fullname: Waters, J. H. organization: University of Pittsburgh – sequence: 7 givenname: D. J. surname: Triulzi fullname: Triulzi, D. J. organization: University of Pittsburgh – sequence: 8 givenname: J. W. A. surname: Hayanga fullname: Hayanga, J. W. A. organization: University of Pittsburgh – sequence: 9 givenname: G. J. surname: Schears fullname: Schears, G. J. organization: Mayo Clinic |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28466601$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kUtP3DAUhS1EBQNl0T-AIrFpF4HrR5yEHUJ9ICGxaSt2luPcUCPHHuyEzvz7mplhg6gly7L1nWOde47Ivg8eCflE4ZzmdfEcVueUVVTskQUVjJcgKOyTBYBgZQtQH5KjlB4BoGFNdUAOWSOklEAXZHnVz24qcDVFbUJchojaFSOOXdQei7BaP6DXkw3-stC-sH7CuL1nLM3xGddFGIqs9mmYU37PWJ_3ZE3QD7PbsMWE5o-3TzOmj-TDoF3Ck915TH59-_rz-kd5e_f95vrqtjSCtqJsuGACWYONlG3dUeCImmuhNQPJhwpqLuXAgHeU64r2lTF00IC87jjvueHH5PPWdxnDy7-TGm0y6FyOFeakaNOKlrFW0IyevUEfw5xTuky1DJgQlawzdbqj5m7EXi2jHXVcq9dZZuBiC5gYUoo4KGOnTfw8HesUBfXSlsptqU1bWfHljeLV9D125_7XOlz_H1S_7-63in_BOKUs |
| CitedBy_id | crossref_primary_10_1186_s43044_025_00630_6 crossref_primary_10_1016_j_redar_2020_12_011 crossref_primary_10_1016_j_thromres_2022_01_013 crossref_primary_10_1016_j_cardfail_2024_07_013 crossref_primary_10_12677_ACM_2023_13112572 crossref_primary_10_1111_trf_15626 crossref_primary_10_1016_j_ccrj_2024_10_003 crossref_primary_10_1097_CCM_0000000000005599 crossref_primary_10_1177_0267659120913803 crossref_primary_10_1111_aor_14879 crossref_primary_10_3390_diagnostics13233496 crossref_primary_10_1016_j_circv_2021_06_006 crossref_primary_10_1177_0267659119830526 crossref_primary_10_1038_s41372_022_01503_5 crossref_primary_10_1016_j_redare_2020_12_002 crossref_primary_10_1097_MAT_0000000000001652 crossref_primary_10_1053_j_jvca_2018_09_003 crossref_primary_10_1016_j_jcrc_2023_154332 crossref_primary_10_31083_j_rcm2204164 crossref_primary_10_1016_j_thromres_2019_01_002 crossref_primary_10_1097_ALN_0000000000003044 crossref_primary_10_1016_j_aan_2017_07_006 crossref_primary_10_1007_s00398_021_00437_y crossref_primary_10_1111_bcp_15251 crossref_primary_10_1053_j_jvca_2023_02_003 crossref_primary_10_1016_j_rpth_2025_102700 crossref_primary_10_1097_JAT_0000000000000247 crossref_primary_10_1177_02676591241253474 crossref_primary_10_1097_MAT_0000000000001166 crossref_primary_10_1111_trf_17505 crossref_primary_10_15420_usc_2023_04 crossref_primary_10_1097_MAT_0000000000001723 crossref_primary_10_1111_ejh_13520 crossref_primary_10_1007_s00063_024_01116_0 crossref_primary_10_1177_08850666241313357 crossref_primary_10_3389_fcvm_2018_00157 crossref_primary_10_1097_ALN_0000000000004920 crossref_primary_10_1016_j_jtcvs_2020_10_079 crossref_primary_10_1164_rccm_202305_0896OC crossref_primary_10_1186_s13054_020_03348_w crossref_primary_10_1016_j_ijoa_2023_103625 crossref_primary_10_1016_j_xjon_2024_11_019 crossref_primary_10_1097_MAT_0000000000002405 crossref_primary_10_1016_j_bpa_2017_07_005 crossref_primary_10_1111_jth_15784 crossref_primary_10_1177_02676591221150880 crossref_primary_10_1111_1744_9987_70009 crossref_primary_10_1051_ject_2024022 crossref_primary_10_1111_trf_15947 crossref_primary_10_1177_02676591221137034 crossref_primary_10_1186_s13054_021_03525_5 crossref_primary_10_1016_j_bpa_2024_10_006 crossref_primary_10_1053_j_jvca_2021_07_046 crossref_primary_10_1016_j_healun_2020_05_015 crossref_primary_10_1053_j_jvca_2024_01_015 crossref_primary_10_1007_s12055_021_01176_3 crossref_primary_10_1186_s40635_024_00596_w crossref_primary_10_1016_j_jcrc_2019_09_013 crossref_primary_10_1097_MD_0000000000030568 crossref_primary_10_1182_asheducation_2018_1_516 crossref_primary_10_1002_phar_2857 crossref_primary_10_3390_jcm12186067 crossref_primary_10_1051_ject_202254223 crossref_primary_10_1177_03913988221148763 crossref_primary_10_1186_s13054_020_2726_9 crossref_primary_10_1002_clc_24273 crossref_primary_10_1097_MJT_0000000000001113 crossref_primary_10_1007_s00296_024_05732_z crossref_primary_10_1097_MAT_0000000000000806 crossref_primary_10_1111_aor_14601 crossref_primary_10_1177_0391398819888932 crossref_primary_10_1097_MAT_0000000000001004 crossref_primary_10_3390_jcm12093224 crossref_primary_10_1007_s40140_020_00384_8 crossref_primary_10_1097_CNQ_0000000000000348 crossref_primary_10_3390_pediatric14030039 crossref_primary_10_3390_brainsci13081165 crossref_primary_10_3390_jcm11175147 crossref_primary_10_23736_S0375_9393_19_13713_3 crossref_primary_10_1177_0897190019830504 crossref_primary_10_1213_ANE_0000000000005738 crossref_primary_10_1053_j_jvca_2020_08_068 crossref_primary_10_1111_jth_14640 crossref_primary_10_17116_anaesthesiology202001125 crossref_primary_10_1097_CCE_0000000000001155 crossref_primary_10_1016_j_jss_2019_05_050 crossref_primary_10_1186_s13019_023_02226_0 crossref_primary_10_1097_PCC_0000000000002160 crossref_primary_10_1111_aor_14104 crossref_primary_10_1177_02676591221129741 crossref_primary_10_1016_j_heliyon_2023_e23210 crossref_primary_10_1186_s12959_022_00396_w crossref_primary_10_1016_j_cjco_2022_02_005 crossref_primary_10_1053_j_jvca_2024_03_042 crossref_primary_10_1212_WNL_0000000000011525 crossref_primary_10_1053_j_jvca_2018_07_045 crossref_primary_10_1002_phar_2230 crossref_primary_10_1097_FJC_0000000000001633 crossref_primary_10_1016_j_accpm_2021_100971 crossref_primary_10_1097_CCM_0000000000004590 crossref_primary_10_1177_08971900221143406 crossref_primary_10_1055_s_0042_1756303 |
| Cites_doi | 10.1097/01.mat.0000247777.65764.b3 10.1213/ANE.0000000000000115 10.1016/j.hlc.2008.08.009 10.1016/j.thromres.2004.06.028 10.1097/00000542-200502000-00007 10.1016/S0022-5223(19)34730-0 10.1161/01.ATV.0000046238.23903.FC 10.1055/s-0038-1655952 10.1016/S0022-5223(94)70150-4 10.1177/039139880602901205 10.1161/01.ATV.0000085629.23209.AA 10.1111/j.1525-1594.2011.01384.x 10.1001/jama.1972.03210050055021 10.1097/EJA.0b013e32835f4d5b 10.1111/j.1423-0410.2008.01110.x 10.1002/j.1875-9114.2011.01049.x 10.1053/j.jvca.2007.09.009 10.1016/1010-7940(91)90145-A 10.1378/chest.124.3_suppl.26S 10.1038/clpt.1990.129 10.1016/S1053-0770(05)80004-7 10.1056/NEJMoa1006221 10.1051/ject/200436116 10.1111/j.1538-7836.2012.04758.x 10.1002/ccd.1810320112 10.1016/S0022-5223(19)34966-9 10.1067/mtc.2002.126038 10.1080/09537100220146398 10.1055/s-0038-1649589 10.1161/hq0701.093686 10.1111/j.1751-2824.2012.01552.x 10.1177/0267659112457969 10.1097/PCC.0000000000000028 10.1016/j.athoracsur.2010.11.078 10.1097/PCC.0b013e31823c98ef 10.1002/ccd.25871 10.1097/00003246-199005000-00006 10.1016/0003-4975(94)90752-8 10.1111/j.1365-2141.1996.tb08989.x 10.1038/sj.mn.7800198 10.1051/ject/200335135 10.1016/j.jtcvs.2004.10.045 10.1016/S0022-3476(96)70252-4 10.1164/ajrccm/138.3.720 10.1111/j.1537-2995.2004.04144.x 10.1177/1089253209347384 10.1097/00003246-199307000-00018 10.1073/pnas.91.19.8767 10.1001/jama.1966.03100180108036 10.1046/j.1537-2995.1996.36196190517.x 10.1093/intqhc/mzg031 10.1080/140174302762659076 10.1177/1089253214532375 10.1016/S0022-5223(19)34156-X 10.1053/j.jvca.2012.02.001 10.1001/jama.1966.03110160071023 10.1016/j.athoracsur.2006.09.054 10.2196/jmir.6.3.e34 10.1097/PCC.0b013e31827127e4 |
| ContentType | Journal Article |
| Copyright | 2017 International Society of Blood Transfusion 2017 International Society of Blood Transfusion. Copyright © 2017 International Society of Blood Transfusion |
| Copyright_xml | – notice: 2017 International Society of Blood Transfusion – notice: 2017 International Society of Blood Transfusion. – notice: Copyright © 2017 International Society of Blood Transfusion |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7TM 7U9 C1K H94 K9. M7N 7X8 |
| DOI | 10.1111/vox.12514 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | Virology and AIDS Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1423-0410 |
| EndPage | 452 |
| ExternalDocumentID | 28466601 10_1111_vox_12514 VOX12514 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 0~B 10A 123 1OB 1OC 29R 30W 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UI 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYIC AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYUIP D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 E0A EAD EAP EBC EBD EBS EGARE EJD EMB EMK EMOBN ESX EX3 F00 F5P FB. FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O1H O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR RKO ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UJ6 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WUP WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ZZTAW ~IA ~WT AAYXX ABBTS ABWCG ACQXL AEYWJ AFSIO AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QL 7T5 7TM 7U9 C1K H94 K9. M7N 7X8 |
| ID | FETCH-LOGICAL-c4194-83424e28e86697b103eea3a4aa2063f507366f203b13a51d5cc1fa0e37b33d3c3 |
| IEDL.DBID | DR2 |
| ISSN | 0042-9007 1423-0410 |
| IngestDate | Fri Jul 11 16:51:17 EDT 2025 Fri Jul 25 10:34:02 EDT 2025 Mon Jul 21 05:54:39 EDT 2025 Tue Jul 01 02:09:32 EDT 2025 Thu Apr 24 23:01:23 EDT 2025 Wed Jan 22 16:27:53 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | cardiopulmonary bypass extracorporeal life support extracorporeal membrane oxygenation bleeding thrombosis anticoagulation |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2017 International Society of Blood Transfusion. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4194-83424e28e86697b103eea3a4aa2063f507366f203b13a51d5cc1fa0e37b33d3c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-4839-8030 |
| PMID | 28466601 |
| PQID | 1920244567 |
| PQPubID | 41227 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1894922941 proquest_journals_1920244567 pubmed_primary_28466601 crossref_citationtrail_10_1111_vox_12514 crossref_primary_10_1111_vox_12514 wiley_primary_10_1111_vox_12514_VOX12514 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | July 2017 |
| PublicationDateYYYYMMDD | 2017-07-01 |
| PublicationDate_xml | – month: 07 year: 2017 text: July 2017 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Amsterdam |
| PublicationTitle | Vox sanguinis |
| PublicationTitleAlternate | Vox Sang |
| PublicationYear | 2017 |
| Publisher | S. Karger AG |
| Publisher_xml | – name: S. Karger AG |
| References | 1966; 196 1966; 198 2005; 130 2013; 28 1990; 18 1993; 21 2002; 13 2003; 15 2004; 6 1996; 36 2012; 13 2012; 10 2003; 10 2009; 13 2009; 96 2013; 14 1990; 48 2000 2005; 102 1993; 70 2015; 86 2004; 36 2014; 15 2006; 29 2008; 22 2014; 18 2012; 26 1972; 222 2003; 124 1994; 108 1988; 138 1994; 32 2014; 118 2004; 44 2002; 36 2006; 52 2012 1992; 103 2008; 17 1992; 104 1996; 94 2003; 35 2010; 363 2011; 35 2007; 53 1993; 105 2012; 32 1996; 10 1996; 129 1991; 5 2011; 9 2001; 21 1991; 28 2004; 114 1997; 77 2011; 91 2002; 124 2013; 30 1994; 58 2007; 83 2013 1994; 91 2012; 7 2003; 23 e_1_2_7_5_1 e_1_2_7_3_1 Hattersley PG (e_1_2_7_47_1) 1966; 198 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_66_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 Agati S (e_1_2_7_59_1) 2006; 52 e_1_2_7_50_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 Colby CE (e_1_2_7_55_1) 2003; 35 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_58_1 e_1_2_7_39_1 Liumbruno GM (e_1_2_7_24_1) 2011; 9 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_16_1 e_1_2_7_40_1 Lawson DS (e_1_2_7_54_1) 2004; 36 e_1_2_7_61_1 e_1_2_7_2_1 Francis CW (e_1_2_7_42_1) 1991; 28 e_1_2_7_14_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_65_1 e_1_2_7_10_1 Borowiec J (e_1_2_7_18_1) 1992; 104 e_1_2_7_46_1 e_1_2_7_48_1 e_1_2_7_27_1 e_1_2_7_29_1 e_1_2_7_51_1 e_1_2_7_30_1 e_1_2_7_53_1 e_1_2_7_32_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_38_1 |
| References_xml | – volume: 18 start-page: 161 year: 2014 end-page: 176 article-title: Pathophysiology of cardiopulmonary bypass: current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction publication-title: Semin Cardiothorac Vasc Anesth – volume: 363 start-page: 1791 year: 2010 end-page: 1800 article-title: Safety of recombinant activated factor VII in randomized clinical trials publication-title: N Engl J Med – volume: 103 start-page: 806 year: 1992 end-page: 813 article-title: Reduced complement activation with heparin‐coated oxygenator and tubings in coronary bypass operations publication-title: J Thorac Cardiovasc Surg – volume: 138 start-page: 720 year: 1988 end-page: 723 article-title: An expanded definition of the adult respiratory distress syndrome publication-title: Am Rev Respir Dis – volume: 10 start-page: 1355 year: 2012 end-page: 1362 article-title: Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa publication-title: J Thromb Haemost – volume: 23 start-page: 1690 year: 2003 end-page: 1696 article-title: Platelet activation induces cell‐surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs publication-title: Arterioscler Thromb Vasc Biol – volume: 13 start-page: 154 year: 2009 end-page: 175 article-title: Anticoagulation and coagulation management for ECMO publication-title: Semin Cardiothorac Vasc Anesth – volume: 10 start-page: 335 year: 2003 end-page: 350 article-title: Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense publication-title: Microcirculation – volume: 124 start-page: 26S issue: 3 Suppl year: 2003 end-page: 32S article-title: The protein C pathway publication-title: Chest – volume: 29 start-page: 1121 year: 2006 end-page: 1131 article-title: Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO) publication-title: Int J Artif Organs – volume: 15 start-page: 261 year: 2003 end-page: 266 article-title: Good practice in the conduct and reporting of survey research publication-title: Int J Qual Health Care – volume: 36 start-page: 351 year: 2002 end-page: 357 article-title: Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface publication-title: Scand Cardiovasc J – volume: 52 start-page: 513 year: 2006 end-page: 516 article-title: Use of a novel anticoagulation strategy during ECMO in a pediatric population: single‐center experience publication-title: ASAIO J – volume: 44 start-page: 1453 year: 2004 end-page: 1462 article-title: The independent association of massive blood loss with mortality in cardiac surgery publication-title: Transfusion – volume: 13 start-page: 247 year: 2002 end-page: 253 article-title: The presence and release of tissue factor from human platelets publication-title: Platelets – volume: 7 start-page: 89 year: 2012 end-page: 91 article-title: Predictors of increased transfusion requirements and optimizing transfusional support in patients on Extracorporeal membrane oxygenation (ECMO) publication-title: ISBT Sci Ser – volume: 13 start-page: e255 year: 2012 end-page: e261 article-title: Hemolytic and thrombocytopathic characteristics of extracorporeal membrane oxygenation systems at simulated flow rate for neonates publication-title: Pediatr Crit Care Med – volume: 108 start-page: 1076 year: 1994 end-page: 1082 article-title: Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti‐Xa heparin concentration in patients having cardiac operations publication-title: J Thorac Cardiovasc Surg – volume: 124 start-page: 852 year: 2002 end-page: 854 article-title: Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII publication-title: J Thorac Cardiovasc Surg – volume: 6 start-page: e34 year: 2004 article-title: Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E‐Surveys (CHERRIES) publication-title: J Med Internet Res – volume: 96 start-page: 34 year: 2009 end-page: 43 article-title: Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation – a single centre experience publication-title: Vox Sang – volume: 36 start-page: 16 year: 2004 end-page: 21 article-title: North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results publication-title: J Extra Corpor Technol – volume: 118 start-page: 731 year: 2014 end-page: 743 article-title: Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion publication-title: Anest Analg – volume: 14 start-page: e77 year: 2013 end-page: e84 article-title: Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey publication-title: Pediatr Crit Care Med – volume: 58 start-page: 799 year: 1994 end-page: 804 article-title: Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation publication-title: Ann Thorac Surg – volume: 21 start-page: 1029 year: 1993 end-page: 1034 article-title: Effect of extracorporeal membrane oxygenation on platelets in newborns publication-title: Crit Care Med – volume: 23 start-page: 17 year: 2003 end-page: 25 article-title: The dynamics of thrombin formation publication-title: Arterioscler Thromb Vasc Biol – volume: 104 start-page: 642 year: 1992 end-page: 647 article-title: Heparin‐coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study publication-title: J Thorac Cardiovasc Surg – volume: 21 start-page: 1094 year: 2001 end-page: 1096 article-title: Mechanism of action and pharmacology of unfractionated heparin publication-title: Arterioscler Thromb Vasc Biol – volume: 130 start-page: 107 year: 2005 end-page: 113 article-title: Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin‐resistant patients during cardiopulmonary bypass publication-title: J Thorac Cardiovasc Surg – volume: 83 start-page: 912 year: 2007 end-page: 920 article-title: Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival publication-title: Ann Thorac Surg – volume: 91 start-page: 944 year: 2011 end-page: 982 article-title: 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines publication-title: Ann Thorac Surg – volume: 5 start-page: 486 year: 1991 end-page: 491 article-title: Heparin‐coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig publication-title: Eur J Cardiothorac Surg – volume: 10 start-page: 458 year: 1996 end-page: 463 article-title: The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery publication-title: J Cardiothorac Vasc Anesth – volume: 105 start-page: 823 year: 1993 end-page: 832 article-title: Blood activation during neonatal extracorporeal life support publication-title: J Thorac Cardiovasc Surg – volume: 9 start-page: 19 year: 2011 end-page: 40 article-title: Recommendations for the transfusion management of patients in the peri‐operative period. I. The pre‐operative period publication-title: Blood Transfus – year: 2000 – volume: 35 start-page: 35 year: 2003 end-page: 38 article-title: Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400 publication-title: J Extra Corpor Technol – volume: 35 start-page: 1024 year: 2011 end-page: 1028 article-title: Antithrombin replacement during extracorporeal membrane oxygenation publication-title: Artif Organs – volume: 28 start-page: 39 year: 1991 end-page: 45 article-title: Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin publication-title: Semin Hematol – volume: 70 start-page: 380 year: 1993 end-page: 385 article-title: Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study publication-title: Thromb Haemost – volume: 94 start-page: 517 year: 1996 end-page: 525 article-title: Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin‐coated extracorporeal circuit publication-title: Br J Haematol – volume: 77 start-page: 270 year: 1997 end-page: 277 article-title: Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass publication-title: Thromb Haemost – volume: 15 start-page: e72 year: 2014 end-page: e79 article-title: Anti‐factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation* publication-title: Pediatr Crit Care Med – volume: 222 start-page: 583 year: 1972 end-page: 584 article-title: Activated coagulation time as screening test publication-title: JAMA – volume: 196 start-page: 436 year: 1966 end-page: 440 article-title: Activated coagulation time of whole blood publication-title: JAMA – volume: 86 start-page: S45 issue: Suppl 1 year: 2015 end-page: S50 article-title: Extracorporeal membrane oxygenation support in acute coronary syndromes complicated by cardiogenic shock publication-title: Catheter Cardiovasc Interv – volume: 32 start-page: 546 year: 2012 end-page: 558 article-title: Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin publication-title: Pharmacotherapy – year: 2012 – volume: 30 start-page: 270 year: 2013 end-page: 382 article-title: Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology publication-title: Eur J Anaesthesiol – volume: 22 start-page: 259 year: 2008 end-page: 260 article-title: Fatal thrombosis after Factor VII administration during extracorporeal membrane oxygenation publication-title: J Cardiothorac Vasc Anesth – volume: 32 start-page: 49 year: 1994 end-page: 52 article-title: Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time publication-title: Cathet Cardiovasc Diagn – volume: 26 start-page: 893 year: 2012 end-page: 909 article-title: Venovenous extracorporeal membrane oxygenation in adults: practical aspects of circuits, cannulae, and procedures publication-title: J Cardiothorac Vasc Anesth – volume: 198 start-page: 243 year: 1966 end-page: 247 article-title: The treatment of classical hemophilia with cryoprecipitates. Laboratory control with readily available tests publication-title: JAMA – volume: 48 start-page: 148 year: 1990 end-page: 154 article-title: Inactivation of Heparin during Extracorporeal‐Circulation in Infants publication-title: Clin Pharmacol Ther – volume: 28 start-page: 54 year: 2013 end-page: 60 article-title: Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation publication-title: Perfusion – volume: 17 start-page: S41 issue: Suppl 4 year: 2008 end-page: S47 article-title: Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients publication-title: Heart Lung Circ – volume: 91 start-page: 8767 year: 1994 end-page: 8771 article-title: P‐selectin induces the expression of tissue factor on monocytes publication-title: Proc Natl Acad Sci U S A – volume: 114 start-page: 321 year: 2004 end-page: 327 article-title: The impact of the inflammatory response on coagulation publication-title: Thromb Res – volume: 53 start-page: 111 year: 2007 end-page: 114 article-title: Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation publication-title: ASAIO J – volume: 36 start-page: 61 year: 1996 end-page: 63 article-title: Blood utilization in adult patients undergoing extracorporeal membrane oxygenated therapy publication-title: Transfusion – volume: 129 start-page: 264 year: 1996 end-page: 268 article-title: Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants publication-title: J Pediatr – volume: 102 start-page: 276 year: 2005 end-page: 284 article-title: A phase III, double‐blind, placebo‐controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin‐resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass publication-title: Anesthesiology – volume: 18 start-page: 494 year: 1990 end-page: 498 article-title: Whole‐blood activated clotting time in infants during extracorporeal membrane‐oxygenation publication-title: Crit Care Med – year: 2013 – ident: e_1_2_7_34_1 – ident: e_1_2_7_58_1 doi: 10.1097/01.mat.0000247777.65764.b3 – ident: e_1_2_7_2_1 doi: 10.1213/ANE.0000000000000115 – ident: e_1_2_7_5_1 doi: 10.1016/j.hlc.2008.08.009 – ident: e_1_2_7_11_1 doi: 10.1016/j.thromres.2004.06.028 – ident: e_1_2_7_37_1 doi: 10.1097/00000542-200502000-00007 – volume: 104 start-page: 642 year: 1992 ident: e_1_2_7_18_1 article-title: Heparin‐coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study publication-title: J Thorac Cardiovasc Surg doi: 10.1016/S0022-5223(19)34730-0 – ident: e_1_2_7_14_1 doi: 10.1161/01.ATV.0000046238.23903.FC – ident: e_1_2_7_33_1 – ident: e_1_2_7_51_1 doi: 10.1055/s-0038-1655952 – ident: e_1_2_7_56_1 doi: 10.1016/S0022-5223(94)70150-4 – ident: e_1_2_7_60_1 doi: 10.1177/039139880602901205 – ident: e_1_2_7_29_1 doi: 10.1161/01.ATV.0000085629.23209.AA – ident: e_1_2_7_35_1 doi: 10.1111/j.1525-1594.2011.01384.x – ident: e_1_2_7_49_1 doi: 10.1001/jama.1972.03210050055021 – ident: e_1_2_7_23_1 doi: 10.1097/EJA.0b013e32835f4d5b – ident: e_1_2_7_19_1 doi: 10.1111/j.1423-0410.2008.01110.x – ident: e_1_2_7_46_1 doi: 10.1002/j.1875-9114.2011.01049.x – ident: e_1_2_7_65_1 doi: 10.1053/j.jvca.2007.09.009 – ident: e_1_2_7_16_1 doi: 10.1016/1010-7940(91)90145-A – ident: e_1_2_7_10_1 doi: 10.1378/chest.124.3_suppl.26S – ident: e_1_2_7_39_1 doi: 10.1038/clpt.1990.129 – volume: 9 start-page: 19 year: 2011 ident: e_1_2_7_24_1 article-title: Recommendations for the transfusion management of patients in the peri‐operative period. I. The pre‐operative period publication-title: Blood Transfus – ident: e_1_2_7_53_1 doi: 10.1016/S1053-0770(05)80004-7 – ident: e_1_2_7_64_1 doi: 10.1056/NEJMoa1006221 – ident: e_1_2_7_32_1 – volume: 36 start-page: 16 year: 2004 ident: e_1_2_7_54_1 article-title: North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results publication-title: J Extra Corpor Technol doi: 10.1051/ject/200436116 – ident: e_1_2_7_31_1 doi: 10.1111/j.1538-7836.2012.04758.x – ident: e_1_2_7_57_1 doi: 10.1002/ccd.1810320112 – ident: e_1_2_7_17_1 doi: 10.1016/S0022-5223(19)34966-9 – ident: e_1_2_7_66_1 doi: 10.1067/mtc.2002.126038 – ident: e_1_2_7_13_1 doi: 10.1080/09537100220146398 – ident: e_1_2_7_45_1 doi: 10.1055/s-0038-1649589 – ident: e_1_2_7_44_1 doi: 10.1161/hq0701.093686 – ident: e_1_2_7_61_1 doi: 10.1111/j.1751-2824.2012.01552.x – ident: e_1_2_7_63_1 doi: 10.1177/0267659112457969 – ident: e_1_2_7_22_1 doi: 10.1097/PCC.0000000000000028 – ident: e_1_2_7_26_1 doi: 10.1016/j.athoracsur.2010.11.078 – ident: e_1_2_7_25_1 doi: 10.1097/PCC.0b013e31823c98ef – volume: 52 start-page: 513 year: 2006 ident: e_1_2_7_59_1 article-title: Use of a novel anticoagulation strategy during ECMO in a pediatric population: single‐center experience publication-title: ASAIO J – ident: e_1_2_7_15_1 doi: 10.1002/ccd.25871 – ident: e_1_2_7_40_1 doi: 10.1097/00003246-199005000-00006 – ident: e_1_2_7_43_1 doi: 10.1016/0003-4975(94)90752-8 – ident: e_1_2_7_28_1 doi: 10.1111/j.1365-2141.1996.tb08989.x – ident: e_1_2_7_12_1 doi: 10.1038/sj.mn.7800198 – volume: 35 start-page: 35 year: 2003 ident: e_1_2_7_55_1 article-title: Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400 publication-title: J Extra Corpor Technol doi: 10.1051/ject/200335135 – ident: e_1_2_7_38_1 doi: 10.1016/j.jtcvs.2004.10.045 – ident: e_1_2_7_36_1 doi: 10.1016/S0022-3476(96)70252-4 – ident: e_1_2_7_41_1 doi: 10.1164/ajrccm/138.3.720 – ident: e_1_2_7_4_1 doi: 10.1111/j.1537-2995.2004.04144.x – ident: e_1_2_7_6_1 doi: 10.1177/1089253209347384 – ident: e_1_2_7_8_1 doi: 10.1097/00003246-199307000-00018 – ident: e_1_2_7_9_1 doi: 10.1073/pnas.91.19.8767 – ident: e_1_2_7_48_1 doi: 10.1001/jama.1966.03100180108036 – volume: 28 start-page: 39 year: 1991 ident: e_1_2_7_42_1 article-title: Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin publication-title: Semin Hematol – ident: e_1_2_7_62_1 doi: 10.1046/j.1537-2995.1996.36196190517.x – ident: e_1_2_7_20_1 doi: 10.1093/intqhc/mzg031 – ident: e_1_2_7_30_1 doi: 10.1080/140174302762659076 – ident: e_1_2_7_50_1 doi: 10.1177/1089253214532375 – ident: e_1_2_7_7_1 doi: 10.1016/S0022-5223(19)34156-X – ident: e_1_2_7_27_1 doi: 10.1053/j.jvca.2012.02.001 – volume: 198 start-page: 243 year: 1966 ident: e_1_2_7_47_1 article-title: The treatment of classical hemophilia with cryoprecipitates. Laboratory control with readily available tests publication-title: JAMA doi: 10.1001/jama.1966.03110160071023 – ident: e_1_2_7_52_1 doi: 10.1016/j.athoracsur.2006.09.054 – ident: e_1_2_7_21_1 doi: 10.2196/jmir.6.3.e34 – ident: e_1_2_7_3_1 doi: 10.1097/PCC.0b013e31827127e4 |
| SSID | ssj0008285 |
| Score | 2.4947903 |
| Snippet | Background and objectives
Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure,... Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac... Background and objectives Extracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure,... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 443 |
| SubjectTerms | Anticoagulants Anticoagulants - pharmacology anticoagulation bleeding Blood Coagulation Blood Transfusion - methods cardiopulmonary bypass Cross-Sectional Studies extracorporeal life support Extracorporeal membrane oxygenation Extracorporeal Membrane Oxygenation - methods Health care Health Care Surveys Heart Heart diseases Hemostasis Hemostatics Heparin - pharmacology Humans Inflammation Inflammatory response Institutions Morbidity Multiple choice Oxygenation Patients Respiratory failure Respiratory therapy Surgery thrombosis Transfusion Whole Blood Coagulation Time |
| Title | Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fvox.12514 https://www.ncbi.nlm.nih.gov/pubmed/28466601 https://www.proquest.com/docview/1920244567 https://www.proquest.com/docview/1894922941 |
| Volume | 112 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB4WD-LF92N9EcXDXro0Tbbb6klEEUEFUdmDUJI0FdFtl93tov56J-nDN4iHQmmmJM3MZL5J0i8Aey4XGgOfclSiYwfzDeUECU8cxSU-5piEWCLt8wv_9Iaf9Tq9BhxU_8IU_BD1hJvxDDteGwcXcvTBySfZc9tEZ8MFavZqGUB09U4dZZjZqt9PQgyEJauQ2cVTv_k5Fn0DmJ_xqg04J3NwVzW12Gfy2M7Hsq1ev7A4_vNb5mG2BKLksLCcBWjodBGmz8ul9iUYHBpmDoJj9xAHTUN3jJCS9HUf60k1wUah6Vm17hORkoePM4tklA8n-oVkCRlbYJybOTkUi_HC-jJxX54aRmoO2dEy3JwcXx-dOuXxDKhIGnInYNzj2gt04PthV1KXaS2Y4EJ4iHsSBJrM9xPPZZIy0aFxRymaCFezrmQsZoqtwFSapXoNCPdiV_pdzy7qIuIMXE21z4WMEZ1QmjShVSkqUiV3uTlC4ymqchjswcj2YBN2a9FBQdjxk9Bmpe2o9NlRhFgXAQsCym4Tdupi9DazhII9m-UoE4Q8xGZy2oTVwkrqWjDQYy7oYknL6vr36qPby569Wf-76AbMeAZR2J3CmzA1HuZ6C_HQWG5bw38DPwoHWw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QH3xPtYzig--dGmabLcVX0SU9VgFUdkXKWmaiqit7G5F_fVO0sMbxIdCaaYkzWQy30zSLwCbNhcKHZ-0ZKwiC-MNaXkxjy3JQ3zMMQgxRNrtU7d1yY86jc4A7JT_wuT8EFXCTVuGma-1geuE9Acrf0qf69o980EY1id6m4Dq_J08SnOzlT-g-OgKC14hvY-nevWzN_oGMT8jVuNyDibgumxsvtPkrp71w7p8_cLj-N-vmYTxAouS3XzwTMGASqZhpF2sts_A464m5yA4fXdx3tSMx4gqyYN6wIoSRbBVOPqMZreJSMjtx-Qi6WXdJ_VC0pj0DTbOdFoOxSK8sL5U3BQHh5GKRrY3C5cH-xd7Las4oQF1SX1ueYw7XDme8lzXb4bUZkoJJrgQDkKfGLEmc93YsVlImWjQqCEljYWtWDNkLGKSzcFQkiZqAQh3Ijt0m45Z10XQ6dmKKpeLMEKAQmlcg61SU4Es6Mv1KRr3QRnGYA8GpgdrsFGJPuacHT8JLZfqDgqz7QUIdxGzIKZs1mC9KkaD06so2LNphjKez31sJqc1mM-HSVUL-noMB20s2TLK_r364OqsY24W_y66BqOti_ZJcHJ4erwEY44GGGbj8DIM9buZWkF41A9XjRW8AaI8C3Y |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8xkNBeBgzGOtjmTTz0JVUcu_nYnhCsgkEBIYr6MClyHBtNG0nVJgj21-_sfKwwJk08RIrii-z47ny_s52fAXZcLhQGPulIrVIH8w3phJprR_IEH3NMQiyR9vDEPxjxr-P-eAE-N__CVPwQ7YSb8Qw7XhsHn6R6zslv8tueic78GSxx3w2NSe-f_-GOMtRszf8nEUbCmlbIbONpX70fjP5CmPcBq404gxX41rS12mjyo1cWSU_-ekDj-MSPWYUXNRIlu5XprMGCyl7C8rBea1-Hya6h5iA4eE9x1DR8x4gpybW6xnoyRbBRaHtWr5-IyMj3-alFMiunN-qO5JoUFhmXZlIOxVK8sL5cXNXHhpGWRHa2AaPBl4u9A6c-nwE1SSPuhIx7XHmhCn0_ChLqMqUEE1wID4GPRqTJfF97LksoE32a9qWkWriKBQljKZPsFSxmeaZeA-Fe6iZ-4NlVXYScoauo8rlIUoQnlOoOdBtFxbImLzdnaPyMmyQGezC2PdiBj63opGLseExou9F2XDvtLEawi4gFEWXQgQ9tMbqbWUPBns1LlAkjHmEzOe3AZmUlbS0Y6TEZdLGka3X97-rjy9OxvXnz_6LvYflsfxAfH54cbcFzz6ALu2t4GxaLaaneIjYqknfWB34Dmj4KLg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adult+extracorporeal+membrane+oxygenation%3A+an+international+survey+of+transfusion+and+anticoagulation+techniques&rft.jtitle=Vox+sanguinis&rft.au=Esper%2C+S.+A.&rft.au=Welsby%2C+I.+J.&rft.au=Subramaniam%2C+K.&rft.au=John+Wallisch%2C+W.&rft.date=2017-07-01&rft.issn=0042-9007&rft.eissn=1423-0410&rft.volume=112&rft.issue=5&rft.spage=443&rft.epage=452&rft_id=info:doi/10.1111%2Fvox.12514&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_vox_12514 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-9007&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-9007&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-9007&client=summon |